Phase 4 Helicobacter Pylori Clinical Trials
17 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–17 of 17 trials
Recruiting
Phase 4
Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication
Helicobacter Pylori InfectionDyspepsia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh80 enrolled2 locationsNCT07537634
Recruiting
Phase 4
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
Helicobacter Pylori Infection
National Taiwan University Hospital450 enrolled1 locationNCT05332444
Recruiting
Phase 4
7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy
Helicobacter Pylori
The First Affiliated Hospital with Nanjing Medical University316 enrolled1 locationNCT07232095
Recruiting
Phase 4
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Gastric CancerHelicobacter Pylori InfectionGastritis+2 more
Yongquan Shi1,248 enrolled1 locationNCT07139366
Recruiting
Phase 4
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Acute Coronary SyndromeHelicobacter Pylori Infection
Qilu Hospital of Shandong University2,600 enrolled42 locationsNCT04728516
Recruiting
Phase 4
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
Helicobacter Pylori Infection
National Taiwan University Hospital360 enrolled1 locationNCT04332848
Recruiting
Phase 4
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
Yongquan Shi400 enrolled1 locationNCT07068607
Recruiting
Phase 4
Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment
Helicobacter Pylori
Second Affiliated Hospital, School of Medicine, Zhejiang University414 enrolled1 locationNCT07122024
Recruiting
Phase 4
Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication
Helicobacter Pylori Infection
Asian Institute of Gastroenterology, India484 enrolled1 locationNCT06959368
Recruiting
Phase 4
VA Dual Sequential Therapy
Helicobacter Pylori Infection
The First Affiliated Hospital with Nanjing Medical University600 enrolled1 locationNCT06929962
Recruiting
Phase 4
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Gastric CancerHelicobacter Pylori InfectionsAtrophic Gastritis
International Agency for Research on Cancer30,000 enrolled1 locationNCT02047994
Recruiting
Phase 4
Doxycycline for Helicobacter Pylori Rescue Treatment
Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine368 enrolled1 locationNCT05874570
Recruiting
Phase 4
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection
Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine200 enrolled10 locationsNCT06561698
Recruiting
Phase 4
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication
the Eradication Rates of Helicobacter Pylori
Xijing Hospital of Digestive Diseases1,404 enrolled1 locationNCT06168214
Recruiting
Phase 4
Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study)
Helicobacter Pylori Infection
Incheon St.Mary's Hospital1,230 enrolled1 locationNCT04147065
Recruiting
Phase 4
Helicobacter Pylori Eradication and Follow-up
Helicobacter Pylori Infection
Shanghai Zhongshan Hospital4,447 enrolled1 locationNCT05061732
Completed
Phase 4
Cure rate and side effects comparison between the sequential bismuth based quadruple therapy and the concomitant bismuth based quadruple therapy in treating patients carrying antibiotic resistant Helicobacter pylori strain.
Helicobacter pylori unable to be eradicated with standard triple therapies.
University of Western Australia200 enrolled1 locationACTRN12615000493549